N/A
N=138
Previvors Recharge: A Resilience Program for Cancer Previvors
Hereditary Cancer · Mental Health Issue
Bottom Line
View on ClinicalTrials.gov: NCT06378749 ↗Enrolled (actual)
138
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Connor Davidson Resilience Scale (CDRISC) — 22.59; 23.53 score on a scale — p=.029
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PreCharge (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Pro-Change Behavior Systems
- Primary completion
- Sep 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Connor Davidson Resilience Scale (CDRISC) |
22.59; 23.53 | .029 sig |
| SECONDARY Acceptance and Action Questionnaire (AAQII) |
27.21; 25.05 | <0.001 sig |
Summary
It is estimated that 1 in 279 people may be carriers of a Hereditary Cancer Syndromes (HCS), a cancer risk that is associated with germline mutations (inherited genetic mutations passed directly from a parent to a child that create a genetic predisposition to certain types of cancer). Individuals with an HCS who have never been diagnosed with cancer (Previvors) have up to an 80% lifetime risk of developing cancer and are at an increased risk of developing multiple primary cancers during their lifetime, often with onset at an early age. Previvors face multiple forms of adversity, including a multitude of annual cancer screenings and the uncertainty of not only their own health but the health of affected family members. This study will examine the acceptability and preliminary effects of PreCharge, a resilience-boosting solution specifically designed for Previvors and delivered primarily via bi-directional text messaging. PreCharge uses proven approaches to behavior change tailoring to increase resilience by promoting a positive mindset, strong social connections, and a deep sense of meaning and purpose while also proactively addressing scanxiety. Up to 150 Hereditary Cancer Previvors will be recruited for a 30-day pilot test. Participants will complete a baseline assessment, and then be provided with 30 days of access to the PreCharge program. At the end of the 30 days, they will be prompted to complete a follow-up assessment. Outcomes to be examined will include pre-post changes on the Connor Davidson Resilience Scale.
Eligibility Criteria
Inclusion Criteria
- Identified as having Hereditary Cancer Syndrome
- Never having been diagnosed with cancer
- Over 18 years of age
- Living in the United States
- English speaking
- Having a score of 26 or below on the Connor Davidson Resilience Scale (10 Item)
- Access to a mobile phone
- Agree to receive text messages.
Data sourced from ClinicalTrials.gov (NCT06378749). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.